RecruitingNot ApplicableNCT07166848
Electrostimulation Study for Ocular Graft vs. Host Disease
Pilot Trial of Non-invasive Electrostimulation in Chronic Ocular Graft-vs-Host Disease
Sponsor
Zhonghui K. Luo, MD, PhD
Enrollment
15 participants
Start Date
Nov 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria3
- Diagnosis of chronic ocular graft vs. host disease (oGVHD) (ICCGVHD criteria probable or definite)
- OSDI score of 22 or higher
- NEI corneal staining score (or modified NEI score) of 2 or higher.
Exclusion Criteria10
- Patients with any open wound on the eyelid.
- Patient with any active cornea ulcer, dacryocystitis, hordeolum, filamentary keratitis, uveitis, retinal detachment, uncontrolled glaucoma or other active pathology per PI's discretion.
- Patient with a pacemaker or ICD.
- Patient currently pregnant or with a potential to be pregnant during the study.
- Patient undergoing any ocular surgical procedure (including intravitreal injections) within the past 3 months.
- Patient undergoing any systemic surgical procedures within 2 months.
- Patient undergoing any non-surgical eyelid procedure such as punctal plugs or punctal cautery within 1 month of study initiation.
- Patients on cytotoxic agents, drugs that inhibit peripheral nerve regeneration (i.e. Gabapentin, Nicotine), radiation therapy, or any other therapy per PI's discretion.
- Patients undergoing immunosuppression regimen change within 1 month of study initiation and/or during the study period.
- Patient who wears contact lens of any kind
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEElectrodes with Currents
Electrodes will be placed on the cheeks and forehead, and treated with an amplitude of 300 µA for 30 mins
DEVICEElectrodes without Currents
Electrodes will be placed on the cheeks and forehead, and treated with an no amplitude for 30 mins
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07166848